Filed: 5/14/2026ACC: 0001622627-26-000015
📋 What this filing means
ROSALIND ADVISORS, INC. filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $248.89M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$248.89M
Total AUM (reported)
44.16M
Total Shares
Allocation by class
COM$113.83M45.7%
COM NEW$113.21M45.5%
SHS NEW$12.07M4.8%
CALL$2.75M1.1%
COM SHS$2.36M0.9%
PUT$2.06M0.8%
COM CL A$1.84M0.7%
Portfolio Concentration
Top 3$67.26M27.0%
4–10$96.87M38.9%
11–25$73.44M29.5%
Rest$11.32M4.5%
Top 3 weight
27.0%
Top 10 weight
65.9%
Voting Authority Distribution
Total shares with voting rights: 44.16M
Sole
Full voting authority
44.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
DELCATH SYSTEMS, INC.
SOLEShares3.30M
TypeSH
Market value$30.63M
12.31%
Sole
3.30M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares3.23M
TypeSH
Market value$18.74M
7.53%
Sole
3.23M
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares2.91M
TypeSH
Market value$17.89M
7.19%
Sole
2.91M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares3.20M
TypeSH
Market value$17.49M
7.03%
Sole
3.20M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares290K
TypeSH
Market value$16.85M
6.77%
Sole
290K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.04M
TypeSH
Market value$13.36M
5.37%
Sole
1.04M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares3.21M
TypeSH
Market value$13.28M
5.33%
Sole
3.21M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares700K
TypeSH
Market value$12.49M
5.02%
Sole
700K
Shared
0.00
None
0.00
MEDIWOUND LTD
SOLEShares749.05K
TypeSH
Market value$12.07M
4.85%
Sole
749.05K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares2.14M
TypeSH
Market value$11.33M
4.55%
Sole
2.14M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares330K
TypeSH
Market value$10.47M
4.21%
Sole
330K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares923.06K
TypeSH
Market value$8.79M
3.53%
Sole
923.06K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares1.53M
TypeSH
Market value$7.35M
2.95%
Sole
1.53M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares100K
TypeSH
Market value$6.77M
2.72%
Sole
100K
Shared
0.00
None
0.00
INSPIREMD INC
SOLEShares3.91M
TypeSH
Market value$6.37M
2.56%
Sole
3.91M
Shared
0.00
None
0.00
ATEA PHARMACEUTICALS INC
SOLEShares1.17M
TypeSH
Market value$6.30M
2.53%
Sole
1.17M
Shared
0.00
None
0.00
PROFOUND MEDICAL CORP
SOLEShares828.12K
TypeSH
Market value$5.37M
2.16%
Sole
828.12K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares250.40K
TypeSH
Market value$4.90M
1.97%
Sole
250.40K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares1.28M
TypeSH
Market value$2.75M
1.10%
Sole
1.28M
Shared
0.00
None
0.00
POLYPID LTD
SOLEShares597.93K
TypeSH
Market value$2.62M
1.05%
Sole
597.93K
Shared
0.00
None
0.00
MYOMO INC
SOLEShares3.85M
TypeSH
Market value$2.60M
1.04%
Sole
3.85M
Shared
0.00
None
0.00
TALPHERA INC
SOLEShares3.35M
TypeSH
Market value$2.51M
1.01%
Sole
3.35M
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares1.11M
TypeSH
Market value$2.46M
0.99%
Sole
1.11M
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$2.36M
0.95%
Sole
125K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares443.76K
TypeSH
Market value$1.84M
0.74%
Sole
443.76K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DELCATH SYSTEMS, INC.SOLE | COM NEW | 3.30M | SH | $30.63M 12.31% | 3.30M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 3.23M | SH | $18.74M 7.53% | 3.23M | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 2.91M | SH | $17.89M 7.19% | 2.91M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.20M | SH | $17.49M 7.03% | 3.20M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 290K | SH | $16.85M 6.77% | 290K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.04M | SH | $13.36M 5.37% | 1.04M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 3.21M | SH | $13.28M 5.33% | 3.21M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 700K | SH | $12.49M 5.02% | 700K | 0.00 | 0.00 |
MEDIWOUND LTDSOLE | SHS NEW | 749.05K | SH | $12.07M 4.85% | 749.05K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 2.14M | SH | $11.33M 4.55% | 2.14M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 330K | SH | $10.47M 4.21% | 330K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 923.06K | SH | $8.79M 3.53% | 923.06K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 1.53M | SH | $7.35M 2.95% | 1.53M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 100K | SH | $6.77M 2.72% | 100K | 0.00 | 0.00 |
INSPIREMD INCSOLE | COM | 3.91M | SH | $6.37M 2.56% | 3.91M | 0.00 | 0.00 |
ATEA PHARMACEUTICALS INCSOLE | COM | 1.17M | SH | $6.30M 2.53% | 1.17M | 0.00 | 0.00 |
PROFOUND MEDICAL CORPSOLE | COM NEW | 828.12K | SH | $5.37M 2.16% | 828.12K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 250.40K | SH | $4.90M 1.97% | 250.40K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | CALL | 1.28M | SH | $2.75M 1.10% | 1.28M | 0.00 | 0.00 |
POLYPID LTDSOLE | COM | 597.93K | SH | $2.62M 1.05% | 597.93K | 0.00 | 0.00 |
MYOMO INCSOLE | COM NEW | 3.85M | SH | $2.60M 1.04% | 3.85M | 0.00 | 0.00 |
TALPHERA INCSOLE | COM NEW | 3.35M | SH | $2.51M 1.01% | 3.35M | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 1.11M | SH | $2.46M 0.99% | 1.11M | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 125K | SH | $2.36M 0.95% | 125K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | COM CL A | 443.76K | SH | $1.84M 0.74% | 443.76K | 0.00 | 0.00 |
Page 1 of 2